scispace - formally typeset
J

Johanna Schleutker

Researcher at Turku University Hospital

Publications -  217
Citations -  13369

Johanna Schleutker is an academic researcher from Turku University Hospital. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 50, co-authored 202 publications receiving 11537 citations. Previous affiliations of Johanna Schleutker include deCODE genetics & National Institutes of Health.

Papers
More filters
Journal Article

ELAC2/HPC2 Involvement in Hereditary and Sporadic Prostate Cancer

TL;DR: It is concluded that rare variants of the ELAC2/HPC2 truncating mutations require additional study as risk factors for PRCA in the general population, but none of the mutations were truncating.
Journal ArticleDOI

Shared heritability and functional enrichment across six solid cancers

Xia Jiang, +333 more
TL;DR: The authors use genome-wide association study summary statistics from six cancer types based on 296,215 cases and 301,319 controls of European ancestry to show that solid tumours arising from different tissues share a degree of common germline genetic basis.
Journal Article

Two Percent of Finnish Prostate Cancer Patients Have a Germ-line Mutation in the Hormone-binding Domain of the Androgen Receptor Gene

TL;DR: It is indicated that the R726L substitution in the AR may confer an up to 6-fold increased risk of prostate cancer and may contribute to cancer development in up to 2% of Finnish prostate cancer patients.
Journal ArticleDOI

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium

TL;DR: Genetically elevated height and BMI were associated with increased mortality (prostate cancer-specific and all-cause, respectively) in men with low-grade disease, a potentially informative but novel finding that requires replication.
Journal ArticleDOI

Androgen receptor CAG polymorphism and prostate cancer risk.

TL;DR: The results suggest that the CAG polymorphism of the AR gene is unlikely to have a major role in the development or progression of PC in the Finnish population, and the association of CAG repeats with the risk of BPH warrants further study.